Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study Meeting Abstract
| Authors: | Gien, L.; Enserro, D.; Block, M.; Waggoner, S.; Duska, L.; Hendrickson, A. W.; Thaker, P.; Backes, F.; Bottsford-Miller, J.; Muller, C.; Disilvestro, P.; Covens, A.; Gershenson, D.; Moore, K.; Aghajanian, C.; Coleman, R. L. |
| Abstract Title: | Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study |
| Meeting Title: | IGCS 2022 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Sep 29-Oct 1 |
| Meeting Location: | New York, NY |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-12-01 |
| Start Page: | A9 |
| Language: | English |
| ACCESSION: | WOS:000899252300015 |
| DOI: | 10.1136/ijgc-2022-igcs.16 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O014/#415 -- Source: Wos |
